Seeking Alpha

Biomarin Pharmaceutical (BMRN): Q2 EPS of -$0.16 beats by $0.14. Revenue of $136.8M (+10.3% Y/Y)...

Biomarin Pharmaceutical (BMRN): Q2 EPS of -$0.16 beats by $0.14. Revenue of $136.8M (+10.3% Y/Y) beats by $2.47M. Shares -1% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)